STAT3 and prostate carcinoma: Given that other reports have identified high STAT3 positivity in bone metastatic prostate cancer21 and that the majority of prostate cancer in humans metastasizes to the skeleton3, we believe that STAT3 may be an important regulator of prostate cancer progression, specifically in bone.